EvoNK Prostate Cancer Immunotherapy
Why is prostate cancer immunotherapy important?
Limitations of existing treatments and differences between LACELLIC
Why EvoNK is different
EvoNK immune cell therapy
The core of prostate cancer immunotherapy proposed by LACELLIC
LACELLIC Prostate Cancer Medical Tour
LACELLIC Medical Tour Package Prostate cancer is a cancer that occurs in prostate tissue influenced by male hormones, and is known to be diagnosed at a higher rate in older people than other cancer types.
In the beginning, there are often no clear symptoms, but as it progresses, changes related to urination such as a delay in urination or a feeling of residual urine, nocturia, and discomfort in the pelvis or lower back may appear.
However, these changes can also occur due to other causes commonly experienced with age, so the disease cannot be diagnosed based on symptoms alone. Confirmation through PSA tests, imaging tests, tissue tests, etc.
and treatment by medical staff should be prioritized. Methods that have been considered together so far
Surgery, radiation therapy, and hormone therapy are widely used for prostate cancer, and treatment plans vary depending on the stage and systemic condition.
These treatments play an important role in suppressing the tumor and managing its progression and are planned and followed at the discretion of the attending medical team.
Meanwhile, as it is a type of cancer that is diagnosed at a high rate in older people, there is ongoing discussion about how to manage the decline in overall physical strength and the burden of daily life that comes with the treatment process.
Immune cells of our body - LACELLIC’s own EvoNK
NK cells are immune cells that originally exist in our body and are known to play a role in recognizing and eliminating abnormal cells.
LACELLIC's EvoNK is an immune cell program that not only collects and mass-cultures these NK cells, but also engineered them to function for a long time in the body.
As a result of experiments at the LACELLIC Cell Regenerative Medicine Research Institute, anti-tumor activity was confirmed to be up to 5 to 20 times higher than that of existing NK cells, and research is being conducted to maintain function even in the tumor microenvironment (TME), where cancer cells interfere with immune attacks.
Here are the points we look at together in the Prostate Cancer Program:
• A hypoallergenic customized approach that lowers physical burden • Protects normal cells and selectively recognizes abnormal cells • Aims for targeted removal of residual cancer and cancer stem cells (CSCs) • Aims for rebuilding systemic immunity that decreases during the treatment process
It consists of an intravenous (IV) method and is carried out without a separate incision or long-term hospitalization. Highly active grade EvoNK treatment Ⅱ for diagnosed patients is available in 10 sets.
However, for prostate cancer, the application and method vary depending on the stage, whether it has metastasized, and the current systemic condition of the hormone treatment or radiation treatment already received.
Since the composition of a program and its applicability to a specific individual are two different issues, priority is given to the individual review process after sufficient testing and consultation with medical staff.
The priority is to continue the standard treatment and regular follow-up currently in progress at the discretion of the medical staff in charge, and the cell program is not a replacement for this. Do not stop treatment arbitrarily and be sure to consult your doctor.
Medical tour information for overseas patients
For overseas patients, not only medical treatment and treatment, but also the schedule before and after visiting Korea must be considered.
It is especially important for elderly patients to consider the burden of their travel and stay schedule in advance. LACELLIC provides consultation regarding treatment schedules and medical tourism so that overseas patients can more conveniently prepare their domestic treatment schedule.
Information on movement and stay after arrival at the airport, remote tracking of immunity levels and follow-up care after returning home, and connection with global partner networks in Southeast Asia, the Middle East, and the Americas are also provided.
The basic schedule is a one-time visit to Korea, from precise diagnosis to cell transplantation, and then repeated visit cycles and ongoing management based on the EvoX platform are reviewed. The specific scope of support may vary depending on the patient's schedule and program and can be confirmed through prior consultation.
The method of application of cell programs may vary depending on the individual's condition. LACELLIC also prioritizes the process of confirming applicability based on sufficient testing and consultation with medical staff.
The activity levels in this text are the results of experiments at the LACELLIC Cell Regenerative Medicine Research Institute and do not guarantee individual treatment results.
The scope of support for global partner network connections may vary depending on the partner organization and country, and may not be available in all regions. Treatment effectiveness may vary depending on the individual.
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul 71-9 Samseong-dong, Gangnam-gu, Seoul
Inquiry +82 10-7667-6057
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul
